Szymańska J A, Zychowicz M, Zelazowski A J, Piotrowski J K
Arch Toxicol. 1978 Apr 27;40(2):131-41. doi: 10.1007/BF01891968.
Subcutaneous administration of bismuth, both single and multiple, resulted in deposition of this metal mainly in the kidneys which contained over 50% of the 'accessible pool' of bismuth. In the kidneys bismuth was bound mainly by the soluble fraction in which it was complexed with a protein of molecular weight of about 7000. Multiple administration of bismuth increased the level of this protein. Selenite administration brought about an increase in the 'accessible pool' of bismuth, probably due to a drop in excretion, and also changes in the organ distribution of this metal. The retention in the kidneys was diminished while those in the liver and in other tissues were augmented. These changes were accompanied by a change in the chemical form of bismuth present in the kidneys manifested by the total disappearance of the protein complex of molecular weight of 7000. The increased synthesis of this protein due to bismuth administration was not abolished completely.
皮下注射铋,无论是单次还是多次注射,都会导致这种金属主要沉积在肾脏中,肾脏中所含的铋占“可及池”的50%以上。在肾脏中,铋主要与可溶性部分结合,在该部分中它与一种分子量约为7000的蛋白质形成复合物。多次注射铋会使这种蛋白质的水平升高。注射亚硒酸盐会导致铋的“可及池”增加,这可能是由于排泄减少以及该金属在器官中的分布发生变化所致。肾脏中的潴留减少,而肝脏和其他组织中的潴留增加。这些变化伴随着肾脏中铋的化学形式的改变,表现为分子量为7000的蛋白质复合物完全消失。由于注射铋而导致的这种蛋白质合成增加并未完全消除。